Individuals harboring mutations in TARDBP and C9ORF72 can develop ALS, FTD or both (ALS/FTD) and hence exhibit motor dysfunction as well as cognitive impairment (Ling et al., 2013; Ferrari et al., 2019). Here, TARDBP is linked to frontotemporal dementia.